Literature DB >> 21280075

SORCS1 alters amyloid precursor protein processing and variants may increase Alzheimer's disease risk.

Christiane Reitz1, Shinya Tokuhiro, Lorraine N Clark, Christopher Conrad, Jean-Paul Vonsattel, Lili-Naz Hazrati, András Palotás, Raphael Lantigua, Martin Medrano, Ivonne Z Jiménez-Velázquez, Badri Vardarajan, Irene Simkin, Jonathan L Haines, Margaret A Pericak-Vance, Lindsay A Farrer, Joseph H Lee, Ekaterina Rogaeva, Peter St George-Hyslop, Richard Mayeux.   

Abstract

OBJECTIVE: Sorting mechanisms that cause the amyloid precursor protein (APP) and the β-secretases and γ-secretases to colocalize in the same compartment play an important role in the regulation of Aβ production in Alzheimer's disease (AD). We and others have reported that genetic variants in the Sortilin-related receptor (SORL1) increased the risk of AD, that SORL1 is involved in trafficking of APP, and that underexpression of SORL1 leads to overproduction of Aβ. Here we explored the role of one of its homologs, the sortilin-related VPS10 domain containing receptor 1 (SORCS1), in AD.
METHODS: We analyzed the genetic associations between AD and 16 SORCS1-single nucleotide polymorphisms (SNPs) in 6 independent data sets (2,809 cases and 3,482 controls). In addition, we compared SorCS1 expression levels of affected and unaffected brain regions in AD and control brains in microarray gene expression and real-time polymerase chain reaction (RT-PCR) sets, explored the effects of significant SORCS1-SNPs on SorCS1 brain expression levels, and explored the effect of suppression and overexpression of the common SorCS1 isoforms on APP processing and Aβ generation.
RESULTS: Inherited variants in SORCS1 were associated with AD in all datasets (0.001 < p < 0.049). In addition, SorCS1 influenced APP processing. While overexpression of SorCS1 reduced γ-secretase activity and Aβ levels, the suppression of SorCS1 increased γ-secretase processing of APP and the levels of Aβ. INTERPRETATIONS: These data suggest that inherited or acquired changes in SORCS1 expression or function may play a role in the pathogenesis of AD.
Copyright © 2010 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21280075      PMCID: PMC3086759          DOI: 10.1002/ana.22308

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  39 in total

1.  Prediction of the coding sequences of unidentified human genes. XIV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.

Authors:  R Kikuno; T Nagase; K Ishikawa; M Hirosawa; N Miyajima; A Tanaka; H Kotani; N Nomura; O Ohara
Journal:  DNA Res       Date:  1999-06-30       Impact factor: 4.458

Review 2.  The secretory pathway from history to the state of the art.

Authors:  C Harter; C Reinhard
Journal:  Subcell Biochem       Date:  2000

3.  Risk of dementia among white and African American relatives of patients with Alzheimer disease.

Authors:  Robert C Green; L Adrienne Cupples; Rodney Go; Kelly S Benke; Timi Edeki; Patrick A Griffith; Mary Williams; Yvonne Hipps; Neill Graff-Radford; David Bachman; Lindsay A Farrer
Journal:  JAMA       Date:  2002-01-16       Impact factor: 56.272

Review 4.  The allelic architecture of human disease genes: common disease-common variant...or not?

Authors:  Jonathan K Pritchard; Nancy J Cox
Journal:  Hum Mol Genet       Date:  2002-10-01       Impact factor: 6.150

5.  The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease.

Authors:  Ekaterina Rogaeva; Yan Meng; Joseph H Lee; Yongjun Gu; Toshitaka Kawarai; Fanggeng Zou; Taiichi Katayama; Clinton T Baldwin; Rong Cheng; Hiroshi Hasegawa; Fusheng Chen; Nobuto Shibata; Kathryn L Lunetta; Raphaelle Pardossi-Piquard; Christopher Bohm; Yosuke Wakutani; L Adrienne Cupples; Karen T Cuenco; Robert C Green; Lorenzo Pinessi; Innocenzo Rainero; Sandro Sorbi; Amalia Bruni; Ranjan Duara; Robert P Friedland; Rivka Inzelberg; Wolfgang Hampe; Hideaki Bujo; You-Qiang Song; Olav M Andersen; Thomas E Willnow; Neill Graff-Radford; Ronald C Petersen; Dennis Dickson; Sandy D Der; Paul E Fraser; Gerold Schmitt-Ulms; Steven Younkin; Richard Mayeux; Lindsay A Farrer; Peter St George-Hyslop
Journal:  Nat Genet       Date:  2007-01-14       Impact factor: 38.330

6.  Association between genetic variants in SORL1 and autopsy-confirmed Alzheimer disease.

Authors:  J H Lee; R Cheng; L S Honig; J-P G Vonsattel; L Clark; R Mayeux
Journal:  Neurology       Date:  2007-10-31       Impact factor: 9.910

7.  SorCS1, a member of the novel sorting receptor family, is localized in somata and dendrites of neurons throughout the murine brain.

Authors:  G Hermey; I B Riedel; M Rezgaoui; U B Westergaard; C Schaller; I Hermans-Borgmeyer
Journal:  Neurosci Lett       Date:  2001-11-02       Impact factor: 3.046

8.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

9.  CDD: a conserved domain database for interactive domain family analysis.

Authors:  Aron Marchler-Bauer; John B Anderson; Myra K Derbyshire; Carol DeWeese-Scott; Noreen R Gonzales; Marc Gwadz; Luning Hao; Siqian He; David I Hurwitz; John D Jackson; Zhaoxi Ke; Dmitri Krylov; Christopher J Lanczycki; Cynthia A Liebert; Chunlei Liu; Fu Lu; Shennan Lu; Gabriele H Marchler; Mikhail Mullokandov; James S Song; Narmada Thanki; Roxanne A Yamashita; Jodie J Yin; Dachuan Zhang; Stephen H Bryant
Journal:  Nucleic Acids Res       Date:  2006-11-29       Impact factor: 16.971

10.  Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease.

Authors:  Hao Li; Sally Wetten; Li Li; Pamela L St Jean; Ruchi Upmanyu; Linda Surh; David Hosford; Michael R Barnes; James David Briley; Michael Borrie; Natalie Coletta; Richard Delisle; Daniella Dhalla; Margaret G Ehm; Howard H Feldman; Luis Fornazzari; Serge Gauthier; Neil Goodgame; Danilo Guzman; Sandra Hammond; Paul Hollingworth; Ging-Yuek Hsiung; Joan Johnson; Devon D Kelly; Ron Keren; Andrew Kertesz; Karen S King; Simon Lovestone; Inge Loy-English; Paul M Matthews; Michael J Owen; Mary Plumpton; William Pryse-Phillips; Rab K Prinjha; Jill C Richardson; Ann Saunders; Andrew J Slater; Peter H St George-Hyslop; Sandra W Stinnett; Jina E Swartz; Rachel L Taylor; John Wherrett; Julie Williams; David P Yarnall; Rachel A Gibson; Michael C Irizarry; Lefkos T Middleton; Allen D Roses
Journal:  Arch Neurol       Date:  2007-11-12
View more
  62 in total

1.  Retromer disruption promotes amyloidogenic APP processing.

Authors:  Christopher P Sullivan; Anthony G Jay; Edward C Stack; Maria Pakaluk; Erin Wadlinger; Richard E Fine; John M Wells; Peter J Morin
Journal:  Neurobiol Dis       Date:  2011-04-16       Impact factor: 5.996

Review 2.  Dyslipidemia and dementia: current epidemiology, genetic evidence, and mechanisms behind the associations.

Authors:  Christiane Reitz
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

3.  The Sorting Receptor SorCS1 Regulates Trafficking of Neurexin and AMPA Receptors.

Authors:  Jeffrey N Savas; Luís F Ribeiro; Keimpe D Wierda; Rebecca Wright; Laura A DeNardo-Wilke; Heather C Rice; Ingrid Chamma; Yi-Zhi Wang; Roland Zemla; Mathieu Lavallée-Adam; Kristel M Vennekens; Matthew L O'Sullivan; Joseph K Antonios; Elizabeth A Hall; Olivier Thoumine; Alan D Attie; John R Yates; Anirvan Ghosh; Joris de Wit
Journal:  Neuron       Date:  2015-08-19       Impact factor: 17.173

4.  SORCS1 is necessary for normal insulin secretory granule biogenesis in metabolically stressed β cells.

Authors:  Melkam A Kebede; Angie T Oler; Trillian Gregg; Allison J Balloon; Adam Johnson; Kelly Mitok; Mary Rabaglia; Kathryn Schueler; Donald Stapleton; Candice Thorstenson; Lindsay Wrighton; Brendan J Floyd; Oliver Richards; Summer Raines; Kevin Eliceiri; Nabil G Seidah; Christopher Rhodes; Mark P Keller; Joshua L Coon; Anjon Audhya; Alan D Attie
Journal:  J Clin Invest       Date:  2014-08-26       Impact factor: 14.808

Review 5.  Impact of late-onset Alzheimer's genetic risk factors on beta-amyloid endocytic production.

Authors:  Cláudia Guimas Almeida; Farzaneh Sadat Mirfakhar; Catarina Perdigão; Tatiana Burrinha
Journal:  Cell Mol Life Sci       Date:  2018-04-27       Impact factor: 9.261

6.  SorLA complement-type repeat domains protect the amyloid precursor protein against processing.

Authors:  Arnela Mehmedbasic; Sofie K Christensen; Jonas Nilsson; Ulla Rüetschi; Camilla Gustafsen; Annemarie Svane Aavild Poulsen; Rikke W Rasmussen; Anja N Fjorback; Göran Larson; Olav M Andersen
Journal:  J Biol Chem       Date:  2014-12-18       Impact factor: 5.157

Review 7.  The role of the retromer complex in aging-related neurodegeneration: a molecular and genomic review.

Authors:  Christiane Reitz
Journal:  Mol Genet Genomics       Date:  2014-10-21       Impact factor: 3.291

Review 8.  Dyslipidemia and the risk of Alzheimer's disease.

Authors:  Christiane Reitz
Journal:  Curr Atheroscler Rep       Date:  2013-03       Impact factor: 5.113

9.  Low-Rank Graph-Regularized Structured Sparse Regression for Identifying Genetic Biomarkers.

Authors:  Xiaofeng Zhu; Heung-Il Suk; Heng Huang; Dinggang Shen
Journal:  IEEE Trans Big Data       Date:  2017-08-04

10.  A Robust Reduced Rank Graph Regression Method for Neuroimaging Genetic Analysis.

Authors:  Xiaofeng Zhu; Weihong Zhang; Yong Fan
Journal:  Neuroinformatics       Date:  2018-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.